Last updated: April 10, 2009
Years published: 1989, 1999, 2007, 2009
Gianotti-Crosti Syndrome is a rare skin disease affecting children between the ages of nine months and nine years. Major symptoms may include blisters on the skin of the legs, buttocks and arms. The disorder is usually preceded by a viral infection.
Gianotti-Crosti Syndrome is characterized by blisters on the skin that may or may not itch. They are usually found on the face, buttocks, arms or legs. The blisters consist of large, flat-topped, fluid filled sacks. They usually occur along with upper respiratory tract infection. The blisters usually last from twenty to twenty-five days; they do not usually recur. There may be an enlargement of the lymph nodes in the trunk area of the body. Gianotti-Crosti Syndrome usually occurs after a bout with a viral disease such as: Coxsackievirus, Hepatitis-B, Infectious Mononucleosis or Cytomegalovirus, or after vaccination with a live virus serum.
The cause of Gianotti-Crosti Syndrome is thought to be a reaction to a previous viral infection. In many countries the predisposing cause is usually the Hepatitis-B virus. In North America other viruses are more often the predisposing cause. The exact reasons for this cause and effect situation are unknown.
Gianotti-Crosti Syndrome usually affects children between the ages of nine months and nine years of age. It affects males and females in equal numbers. Although the disorder is regularly associated with Hepatitis-B infections in other countries, in North America it is rarely the cause.
Because Gianotti-Crosti Syndrome is a self-limiting disorder, the treatment of affected children is primarily symptomatic and supportive. For example, in some cases, the use of topical ointments or certain medications by mouth may be recommended to help alleviate mild to potentially severe itching (pruritus). The skin lesions associated with Gianotti-Crosti Syndrome typically spontaneously resolve within approximately 15 to 60 days. When associated findings include enlargement of the lymph nodes (lymphadenopathy) and/or enlargement of the liver (i.e., in association with liver inflammation [hepatitis]), such findings may persist for several months after initial symptom onset.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. Government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]
For information about clinical trials sponsored by private sources, contact:
www.centerwatch.com
TEXTBOOKS
Nelson Textbook of Pediatrics, 15th Ed.: Richard E. Behrman, Editor; W.B. Saunders Company, 1996. P. 1868.
JOURNAL ARTICLES
The Gianotti-Crosti Syndrome. D. Rubenstein et al.; Pediatrics (March 1978; 61 (3)). Pp. 433-37.
Gianotti-Crosti Syndrome. A Review of Ten Cases Not Associated with Hepatitis-B. K.L. Spear et al.; Arch Dermatol (July 1984; 120 (7)). Pp. 891-96.
Gianotti-Crosti Syndrome: A Study of 26 Cases. A. Taieb et al.; Br J Dermatol (July 1986; 115, (1)). Pp. 49-59.
An Epidemic of Infantile Papular Acrodermatitis (Gianotti-Crosti Syndrome) Due to Epstein-Barr Virus. U. Baldari et al.; Dermatology (1994; 188(3)). Pp. 203-04.
Gianotti-Crosti Syndrome in Epstein-Barr Virus Infection. R.E. Schopf; Hautarzt (Oct 1995; 46(10)). Pp. 714-16.
Case Report: Gianotti-Crosti Syndrome Associated with Human Herpesvirus-6 Infection. S. Yasumoto et al.; J Dermatol (Jul 1996; 23(7)). Pp. 499-501.
Gianotti-Crosti Syndrome due to a Mixed Infection Produced by the Mumps Virus and the Parainfluenza Virus Type 2. R. Hergueta Lendinez et al.; An Esp Pediatr (Jan 1996; 44(1)). Pp. 65-66.
Gianotti-Crosti Syndrome Associated with Epstein-Barr Virus Infection. B. Hofmann et al.; Pediatr Dermatol (Jul-Aug 1997; 14(4)). Pp. 273-77.
Papular Acrodermatitis of Childhood Related to Poxvirus and Parvovirus B19 Infection. J.M. Carrascosa et al.; Cutis (May 1998; 61(5)). Pp. 265-67.
Gianotti-Crosti Syndrome: Clinical, Serologic, and Therapeutic Data from Nine Children. K. Boeck et al.; Cutis (Dec 1998; 62(6)). Pp. 271-74. Quiz: P. 286.
Gianotti-Crosti Syndrome Related To Rotavirus Infection (letter). V. Di Lernia; Pediatr Dermatol (Nov-Dec 1998; 15(6)). Pp. 485-86.
FROM THE INTERNET
eMedicine-Gianotti-Crosti Syndrome: Article by Kara N Shah, MD, Ph.D
hhtp://www.emedicine.com/derm/topic165.htm
NORD strives to open new assistance programs as funding allows. If we donโt have a program for you now, please continue to check back with us.
NORD and MedicAlert Foundation have teamed up on a new program to provide protection to rare disease patients in emergency situations.
Learn more https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/Ensuring that patients and caregivers are armed with the tools they need to live their best lives while managing their rare condition is a vital part of NORDโs mission.
Learn more https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.
Learn more https://rarediseases.org/patient-assistance-programs/caregiver-respite/